Skip to main content
Current Urology logoLink to Current Urology
. 2021 Nov 22;15(4):248. doi: 10.1097/CU9.0000000000000058

Experience of a Tertiary-Level Urology Center in Clinical Urological Events of Rare and Very Rare Incidence. V. Urological Tumors: 1. Adrenal Myelolipoma: Erratum

PMCID: PMC8785813  PMID: 35082584

In the article entitled “Experience of a Tertiary-Level Urology Center in Clinical Urological Events of Rare and Very Rare Incidence. V. Urological Tumors: 1. Adrenal Myelolipoma” published in Current Urology 2020;14(2):85–91 (DOI: 10.1159/000499254), the following Statement of Ethics was omitted: “According to the local legislation and institutional requirements, ethical review and approval for retrospective studies was not required. However, in our center, written consent is always taken from each patient for treatment and surgery including his counseling about the policies of the institute as an academic research and teaching university hospital that allow publishing scientific data without identifying the patient's identity or violating his confidentiality. All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

In addition, the author name “Dia A Hameed” should be corrected as “Diaa A Hameed.”

We apologize for the above errors and any inconvenience they may have caused.

Reference

  1. Gadelkareem RA, Moeen AM, Khalil M, et al. Experience of a Tertiary-Level Urology Center in Clinical Urological Events of Rare and Very Rare Incidence. V. Urological Tumors: 1. Adrenal Myelolipoma. Curr Urol 2020;14(2):85–91. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Current Urology are provided here courtesy of Wolters Kluwer Health

RESOURCES